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Summary : This study investigated the effects of extracellular magnesium concentration ([Mg 2+ ]e¥; 0.3‐3 mM) on intracellular free calcium concentration ([Ca 2+ ]i) 
and prostacyclin (PGI 2) production in cultured human umbilical vein endothelial cells (HUVEC) and vascular smooth muscle cells from rats (VSMC) under basal and 
agonist‐stimulated conditions. We used histamine as agonist which increases [Ca 2+ ]i and PGI 2 production in HUVEC, norepinephrine in VSMC. [Mg 2+ ]e
dose‐dependently increased basal and agonist‐stimulated PGI 2 production in both cells. [Mg 2+ ]e dose‐dependently reduced basal [Ca 2+ ]i in VSMC, but did not 
influence in HUVEC. In both cells, increasing [Mg 2+ ]e reduced agonist‐stimulated [Ca 2+ ]i responses. Furthermore, [Mg 2+ ]e dose‐dependently reduced 
agonist‐stimulated [Ca 2+ ]i in Ca 2+ ‐free buffer, indicating intracellular Ca 2+ release. In VSMC, 10 ‐‐6 M diltiazem and 10 ‐7 M nifedipine, Ca 2+ channel blockers, 
reduced agonist‐stimulated [Ca 2+ ]i as well as 3 mM Mg 2+, but did not affect PGI 2 production. [Mg 2+ ]e amplified dose‐dependently arachidonic acid‐induced PGI 2
production in both cells, suggesting the activation of cyclooxygenase and¥¥or PGI 2 synthetase. Our results suggest that [Mg 2+ ]e influences intracellular Ca 2+
mobilization of not only vascular smooth muscle cells but also endothelial cells by inhibiting both Ca 2+ influx and intracellular Ca 2+ release. [Mg 2+ ]e enhances PGI 2
production in both types of cells, although the mechanism is likely to be independent from Ca 2+ mobilization. 
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Introduction 
Several types of cultured cells, including both endothelial and smooth muscle cells of the vessel wall, can synthesize prostacyclin (PGI2), a potent vasodilator which 
inhibits platelet function [1, 2]. Prostaglandin (PG) synthesis requires Ca2+ since PG production is stimulated by an increase in cytosolic free Ca2+ concentration 
([Ca2+]i) and is suppressed by a decrease in [Ca2+]i [3, 4]. Agonists such as histamine, norepinephrine that increase [Ca2+]i promote PGI2 synthesis in vascular 
endothelial cells or smooth muscle cells [5, 6]. 
Magnesium ion (Mg2+) modulates the influx of extracellular Ca2+ and the release of intracellular Ca2+ stores in smooth muscle cells [7, 8]. An elevation or decrease of
the extracellular Mg2+ concentration ([Mg2+]e) will respectively rapidly inhibit or potentiate vascular contractile tension. However, few investigations of the influence of
[Mg2+]e on [Ca2+]i in vascular endothelial cells have been done [9, 10]. 
Watson et al. showed that [Mg2+]e amplifies the basal release of PGI2 by endothelial cells [11]. However, the mechanisms by which Mg2+ promotes vascular endothelial 
cells to produce PGI2 are not well understood. Furthermore, it is unknown whether [Mg2+]e amplifies PGI2 synthesis in endothelial cells under agonist-stimulated 
conditions. Since [Mg2+]e suppresses [Ca2+]i in vascular smooth muscle cells, it is also unknown whether Mg2+ amplifies PGI2 synthesis in vascular smooth muscle cells 
under basal and agonist-stimulated conditions. 
The present study explored the influence of [Mg2+]e on the functional properties of endothelial and smooth muscle cells by increasing [Mg2+]e in the incubation media 
from 0.3 to 3 mM. The concentration of 0.3 mM [Mg2+]e corresponds to the lowest physiological level of this ion which can be measured in human serum, the 1 mM 
[Mg2+]e to the physiological level, and the 3.0 mM [Mg2+]e to the level reached by therapeutic supplementation of Mg2+ in patients with arrhythmia or preeclampsia. We 
 
explored the effects of [Mg2+]e on basal [Ca2+]i and agonist-stimulated [Ca2+]i transients, on basal PGI2 production and agonist-stimulated PGI2 production in cultured 
vascular endothelial cells and smooth muscle cells. We further compared the effect of [Mg2+]e on PGI2 production in smooth muscle cells with that of L-type Ca2+
channel blockers, nifedipine and diltiazem. 
Materials and Methods 
Materials 
Norepinephrine, histamine, and indomethacin were purchased from Sigma Chemical Co. (ST. Louis, MO). Sodium arachidonic acid was purchased from Nu-Check 
Prep. Inc. (Elysian, MN). 3H-6-keto PGF1α was obtained from New England Nuclear (Boston, MA). Medium 199 (M-199) and Dulbecco's modified Eagle's medium 
(DMEM) were purchased from GIBCO (Grand Island, NY). Both 6-keto-PGF1α and anti-6-keto PGF1α antibody were kindly supplied by Ono Pharmaceutical Co. 
(Osaka, Japan). Fura-2/acetoxymethyl ester (fura-2AM) was obtained from Nacalai Tesque (Kyoto, Japan). Diltiazem HCl and nifedipine were kindly supplied by 
Tanabe Pharmaceutical Co. (Tokyo, Japan) and Bayer Pharmaceutical Co. (Osaka, Japan) respectively. 
Cell isolation and culture 
Endothelial cells were prepared from the human umbilical vein by enzymatic dissociation using techniques similar to those described previously from our laboratory 
[12]. Human umbilical vein endothelial cells (HUVEC) were cultured in M-199 supplemented with 50 µg/ml endothelial cell growth factor (Collaborative Research, Inc.,
Waltham, MA), 20% fetal calf serum (FCS), 1% glutamine, 100 U/ml porcine intestinal heparin (Sigma) and 1% penicillin-streptomycin. Cultures were maintained at 
37 °C in 95% O2/5% CO2 and used at passages 2-3. 
Vascular smooth muscle cells (VSMC) were isolated from the thoracic aorta of Sprague-Dawley rats (200-250 g) by the modified explant method of Ross [13] and were 
cultured in DMEM, supplemented with 10% FCS, and 1% penicillin-streptomycin, maintained at 37 °C in 95% O2/5% CO2, and used at passages 4-8. Cultured cells 
were identified as smooth muscle cells by their typical hill-and-valley morphology and by immunocytochemistry using HHF-35, a monoclonal antibody that recognizes 
muscle-specific actin [14]. 
PGI2 Determination 
Confluent monolayers of HUVEC in 12-well culture dishes were washed three times with 1 ml of M-199, and then incubated for 20 min at 37 °C with Hepes buffer A 
(5.5 mM dextrose, 137 mM NaCl, 5 mM KCl, 10 mM Hepes, 1.8 mM CaCl2, pH 7.35) containing various concentrations of MgSO4 (0.3-3 mM) [11] in the presence or 
absence of 10–5 M histamine, or 2 × 10–5 M sodium arachidonate. We used MgSO4 in the present study, since Watson et al. showed that MgSO4 amplifies the basal 
release of PGI2 by endothelial cells as well as MgCl2 [11]. Confluent VSMC in 6-well culture dishes were washed three times with 1 ml of DMEM, and then incubated 
for 20 min at 37 °C with Hepes buffer A containing various concentrations of MgSO4 in the presence or absence of 10–6 M norepinephrine or 2 × 10–5 M sodium 
arachidonate. In the experiments using L-type Ca2+ channel blockers, either 10–6 M diltiazem or 10–7 M nifedipine was added to Hepes buffer A containing 1 mM 
MgSO4. After incubation, the cell-free supernatant from each well was taken for the analysis of the PGI2 concentration. After aspiration, the cells were trypsinized with 
saline-trypsin-versen (0.05% trypsin and 0.02% EDTA in phosphate-buffer saline [PBS]), harvested and counted in a hemocytometer using phase-microscopy. PGI2
was quantitated by standard radioimmunoassay of its hydration product (6-keto-PGF1α) using phosphate-gelatin buffer (50 mM KH2PO4, 0.14 M NaCl, 0.1% gelatin, pH 
7.4), a 1:2000 dilution of antibody, and 10000-dpm of 3H-6-keto PGF1α. After overnight incubation at 4 °C, charcoal-coated dextran was used to separate bound from 
unbound radioactivity. This assay can detect as little as 200 pg/ml of 6-keto-PGF1α. 
Measurement of intracellular free Ca2+ concentration 
The confluent HUVEC and VSMC in the 100 mm cultured dishes were trypsinized with saline-trypsin-versen to disperse. After centrifugation, cells were resuspended
in physiological buffer (145 mM NaCl, 10 mM glucose, 5 mM KCl, 1 mM MgCl2, 10 mM Hepes, 2 mM CaCl2, pH 7.45) containing 10% FCS, 2 µM fura-2AM, and 
incubated for 30 minutes at 37 °C. The cells were washed once with PBS and maintained for 20 minutes at room temperature. The loaded cells were washed,
centrifuged, resuspended at 1 × 106 cells/ml in Hepes buffer B (118 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 1.2 mM KH2PO4, 5 mM Hepes, 10 mM glucose and 1 mg/ml 
bovine serum albumin [BSA], pH7.4) containing various MgSO4 concentrations (0.3-3 mM). Where Ca2+ -free conditions were required, the fura-2AM-loaded cells were 
resuspended in fresh buffer B without CaCl2, but containing 0.1 mM EGTA and various MgSO4 concentrations (0.3-3 mM). The suspensions were placed in quartz 
cuvettes containing a stir bar and then fluorescent measurements were made at 37 °C with two-wave spectrofluorophotometer, RF-5000 (Shimazu Co. Ltd., Kyoto, 
Japan). The excitation wavelengths were 340 and 380 nm, with emission at 500 nm. The time taken to switch between the 340 and 380 nm excitation wavelengths 
was 0.8 sec. [Ca2+]i was calculated every 1.6 sec from the ratio (R) of the 340 nm/380 nm fluorescent values using equation of Grynkiewicz et al. [15]: 
[Ca2+]i = Kd × (R – Rmin)/(Rmax – R) × β 
A Kd is the affinity of fura-2 for Ca2+ (224 nM at 37 °C) and β is the ratio of the fluorescence values obtained at 380 nm in the absence and presence of saturating 
[Ca2+]i The maximum fluorescence intensity ratio (Rmax) was obtained by permeabilizing the cells with 10% Triton-X, which exposed the dye to the Ca2+ concentration 
of the assay buffer. The minimum fluorescence intensity ratio (Rmin) was obtained by chelating Ca2+ with 10 mM EGTA. 
Statistical analysis 
Data are expressed as means ± standard errors. Differences were tested for statistical significance by one way ANOVA followed by an unpaired Student's t test. A 
level of P < 0.05 were considered to be statistically significant. 
Results 
Effects of extracellular Mg2+ on basal and agonist-stimulated PGI2 production by HUVEC 
When cultured HUVEC monolayers were incubated in Hepes buffer A with various concentrations of MgSO4, [Mg2+]e dose-dependently increased basal release of 
PGI2 by HUVEC (figure 1). [Mg2+]e also increased 10–5 M histamine-stimulated PGI2 production by HUVEC. 
Effects of extracellular Mg2+ on basal and agonist-stimulated [Ca2+]i in HUVEC. 
Lowering or raising [Mg2+]e did not affect basal [Ca2+]i in HUVEC. However, when HUVEC were treated with 10–5 M histamine, increased [Mg2+]e suppressed the [Ca2+]i
transients (figure 2A). To assess the involvement of extracellular Ca2+ concentration in the effect of [Mg2+]e on histamine-stimulated [Ca2+]i transients, similar 
experiments were performed in Ca2+ -free Hepes buffer containing 0.1 mM EGTA. Also in Ca2+ -free buffer, increasing extracellular Mg2+ slightly but significantly 
reduced histamine-stimulated [Ca2+]i transients, although it did not affect basal [Ca2+]i (figure 2B). These results indicate that the effects of [Mg2+]e on the 
histamine-stimulated [Ca2+]i transients in HUVEC are caused by both the suppression of Ca2+ influx and its release from intracellular stores. 
Effects of extracellular Mg2+ on PGI2 production and [Ca2+]i in VSMC 
When cultured VSMC were incubated with various MgSO4 concentrations, the basal release of PGI2 was increased in a Mg2+ concentration dependent manner. [Mg2+]e
also increased 10–6 M norepinephrine-stimulated PGI2 production in a concentration-dependent manner (figure 3). 
In contrast to HUVEC, increased [Mg2+]e dose-dependently reduced basal [Ca2+]i in VSMC (0.3 mM [Mg2+]e: 207.8 ± 12.8 nM; 1 mM [Mg2+]e: 107.3 ± 2.8 nM; 3 mM 
[Mg2+]e: 89.3 ± 2.5 nM). [Mg2+]e significantly suppressed agonist-stimulated [Ca2+]i transients in VSMC (0.3 mM [Mg2+]e:451.9 ± 12.0 nM; 1 mM [Mg2+]e: 298.0 ± 8.5 nM; 
3 mM [Mg2+]e:182.6 ± 8.7 nM). 
Effects of Ca2+ channel blockers on [Ca2+]i and PGI2 production in VSMC 
Since Mg2+ is called a nature's physiologic Ca2+ channel blocker, we compared the effects of Mg2+ with those of synthetic Ca2+ channel blockers on PGI2 production by 
VSMC. As shown in figure 4A, when 10–6 M diltiazem or 10–7 M nifedipine were added to the VSMC in Hepes buffer B containing 1 mM MgSO4, agonist-stimulated 
[Ca2+]i transients were suppressed. This suppression was same degree as that for [Ca2+]i transients in Hepes buffer B containing 3 mM MgSO4 in the absence of Ca2+
channel blockers. However, as shown in figure 4B, neither Ca2+ channel blocker affected agonist-stimulated PGI2 production by VSMC, while high [Mg2+]e (3 mM) 
increased agonist-stimulated PGI2 production. These results suggest that the Mg2+ effect on PGI2 production is not caused by regulation of [Ca2+]i. 
Effects of extracellular Mg2+ on sodium arachidonate-stimulated PGI2 production by HUVEC and VSMC 
Arachidonic acid liberated from the cell membrane by phospholipase A2 (PLA2), a key enzyme in PGI2 production, is converted to PGI2 by two other key enzymes, 
cyclooxygenase and PGI2 synthetase. In order to probe the effect of Mg2+ on activities of cyclooxgenase and PGI2 synthetase, 2 × 10–5 M exogenous sodium 
arachidonate was added to HUVEC or VSMC in Hepes buffer A with various concentrations of MgSO4. As shown in figure 5, [Mg2+]e dose-dependently increased the 
sodium arachidonate-induced PGI2 production by HUVEC and VSMC. 
Discussion 
[Mg2+]e influences the tone and reactivity of veins and arteries, and even small changes in [Mg2+]e exert significant effects on vascular smooth muscle contractility [16,
17, 18]. In vivo and in vitro studies have demonstrated that elevation of [Mg2+]e inhibits spontaneous tone of arteries, dose-dependently dilates vessels and attenuates 
agonists-stimulated contraction [16, 19]. It has been reported that [Mg2+]e dose-dependently reduced basal and agonists (vasopressin, angiotensin II)-stimulated [Ca2+]i
responses in cultured VSMC [7, 8, 20]. The present study also demonstrated that [Mg2+]e dose-dependently reduced basal and agonist (norepinephrine)-stimulated 
[Ca2+]i responses in cultured VSMC. On the other hand, few investigations have been done on the influence of [Mg2+]e on [Ca2+]i under basal and agonist-stimulated 
conditions in endothelial cells. An elevation of [Ca2+]i is known to be closely coupled to important functional properties of vascular endothelial cells, such as
synthesis/release of bioactive substances in response to a number of agonists or physical stimuli [21]. This elevated [Ca2+]i in endothelial cells results from an influx of 
extracellular Ca2+ through ionic channels and release of intracellular Ca2+ stores [22]. Our study demonstrated that [Mg2+]e suppressed the histamine-induced [Ca2+]i
responses in HUVEC, by suppressing both an influx of extracellular Ca2+ and release from intracellular Ca2+ stores. These findings suggest that changes of [Mg2+]e
may affect important functions of vascular endothelial cells. 
Watson et al. [11] showed that Mg2+ directly amplifies the basal release of PGI2 by HUVEC. Nadler et al. reported that MgSO4 infusion produced a significant increase 
in the renal excretion of the stable PGI2 metabolite in humans [23]. However, the mechanisms by which Mg2+ promotes PGI2 production are not well understood. In this 
study, we have shown for the first time that extracellular Mg2+ dose-dependently promoted basal PGI2 production by not only HUVEC but also VSMC, and 
agonist-stimulated PGI2 production by both cells. 
Studies of the molecular structure and function of PLA2, a key enzyme in PGI2 production, have shown a calcium requirement for PG synthesis [4, 24]. Ca2+ is needed 
for cytosolic PLA2 to translocate from the cytoplasmic region to the cell membrane where the PLA2 stimulates the release of arachidonic acid [3]. Histamine-induced 
PGI2 production by HUVEC is associated with a concentration-dependent discharge of the internal Ca2+ stores and a subsequent influx of extracellular Ca2+, thereby 
activating PLA2 [25, 26]. In our study, Mg2+ promoted the histamine- or norepinephrine-stimulated PGI2 production by HUVEC or VSMC, even though Mg2+ suppressed 
the agonist-stimulated [Ca2+]i responses in both cells. However, while synthetic Ca2+ channel blockers suppressed agonist-stimulated [Ca2+]i responses, as did Mg2+, 
they did not produce an effect similar to Mg2+ on PGI2 production. The mechanism by which Mg2+ promotes PGI2 production is thus likely to be independent of [Ca2+]i
changes. 
Mg2+, which is called nature's physiologic Ca2+ channel blocker, has the effect of activating various enzymes, being different from synthetic Ca2+ channel blockers. For 
example, Mg2+ is a cofactor in the activation of phosphorylases, adenylate cyclase, and ATPase [16, 27]. Cyclooxgenase and PGI2 synthetase convert the endogenous 
arachidonic acid to PGI2. In this study, extracellular Mg2+ amplified exogenous sodium arachidonate-stimulated PGI2 production by HUVEC and VSMC. Our results 
suggest that Mg2+ stimulate not PLA2 activity but cyclooxygenase and/or PGI2 synthetase activity. 
Conclusion 
[Mg2+]e suppressed the [Ca2+]i rise induced by vasoactive agents not only in VSMC but also in vascular endothelial cells. Furthermore, [Mg2+]e promoted either basal or 
vasoactive agents-stimulated PGI2 production by vascular endothelial cells and smooth muscle cells. Synthetic Ca2+ channel blockers did not have this effect. 
Maintaining a physiological serum concentration of Mg2+ is clinically important for the regulation of vascular tone. Indeed, Mg2+ deficiency is associated with numerous 
cardiovascular disorders, which are associated with changes in vascular tone, including hypertension, myocardial infarction, and vasospastic angina [28, 29]. Our 
results suggest that extracellular Mg2+ regulates vascular tone by antagonizing the effects of Ca2+ in smooth muscle cells and modulating the synthesis of biologically 
active substances such as PGI2 by the vascular endothelial cells and smooth muscle cells. Further study is required to clarify the actions of intracellular Mg2+ and its 
effects on several enzyme activities in these cells. 
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Fig. 1. Effects of extracellular Mg2+ on basal and agonist-stimulated PGI2 production by HUVEC. Cultured HUVEC were incubated in Hepes buffer A (see Methods) 
containing 0.3-3 mM Mg2+ in the presence (close circle) or absence (open circle) of 10–5 M histamine. The supernatant was assayed by RIA. Data are represented as 
means ± SEM (n = 6). * P < 0.05 compared with 0.3 mM Mg2+ 
 
Fig. 2. Effects of extracellular Mg2+ on basal [Ca2+]i and 10–5 M histamine-stimulated [Ca2+]i transients in HUVEC. Cultured HUVEC were loaded with 2 µM fura2-AM 
and resuspended in Hepes buffer B (see Methods) containing 0.3-3 mM MgSO4 with (Panel A) or without (Panel B) 2.5 mM CaCl2 Data were obtained in the presence 
(close circle) or absence (open circle) of 10–5 M histamine. Data are represented as means ± SEM (n = 8). * P < 0.05 compared with 0.3 mM Mg2+. 
 
Fig. 3. Effects of extracellular Mg2+ on PGI2 production by VSMC. Cultured VSMC were incubated in Hepes buffer A (see Methods) containing 0.3-3 mM Mg2+ in the 
presence (close circle) or absence (open circle) of 10–6 M norepinephrine. The supernatant was assayed by RIA. Data are represented as means ± SEM (n = 8). * 
P < 0.05 compared with 0.3 mM Mg2+. 
 
Fig. 4. Effects of Ca2+ channel blockers on 10–6 M norepinephrine-stimulated [Ca2+]i transients and PGI2 production in VSMC. Panel (A) demonstrates 10–6 M 
norepinephrine-stimulated [Ca2+]i transients in Hepes buffer B (see Methods). Panel (B) shows 10–6 M norepinephrine-stimulated PGI2 production in Hepes buffer A 
(see Methods). Data are represented as means ± SEM (n = 8). * Significantly different at P < 0.05. NS indicates no statistically significant difference. 
 
Fig. 5. Effects of extracellular Mg2+ on sodium arachidonate-stimulated PGI2 production by HUVEC and VSMC. HUVEC and VSMC were incubated in Hepes buffer A 
(see methods) containing 0.3-3 mM Mg2+ with 20 µM arachidonic acid (Panel (A): HUVEC, Panel (B): VSMC). The supernatant was assayed by RIA. Data are 
represented as means ± SEM (n = 8). * Significantly differs (P < 0.05) from corresponding values obtained with 0.3 mM Mg2+ * P < 0.05 compared with 0.3 mM Mg2+. 
 
 
